Lawrenceville, NJ, United States of America

Donald G Jackson

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Donald G. Jackson

Introduction

Donald G. Jackson is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of immunology and cancer research. With a total of 5 patents, his work has paved the way for advancements in therapeutic interventions.

Latest Patents

Among his latest patents is the invention related to polynucleotides encoding human SLAP-2 variants, specifically hSLAP-2v3. This invention focuses on the identification and cloning of two novel full-length human SLAP-2 variants and their encoded polypeptides. These variants, hSLAP-2v3 and hSLAP-2v4, are crucial in the negative regulation of intracellular T-cell signal transduction. The application of these polynucleotides and their polypeptides is significant for therapeutic interventions in various disorders, including immunological and inflammatory disorders, autoimmune diseases, pulmonary diseases, proliferative immune disorders, and cancer.

Another important patent involves human histone deacetylase, HDAC9c. This invention encompasses newly discovered human histone deacetylases, also known as histone deacetylase-like polypeptides. The patent includes polynucleotide sequences and encoded polypeptides of these novel HDACs, as well as vectors and host cells comprising these sequences. The invention also covers antibodies that bind to the disclosed HDAC polypeptides and methods for screening modulators, which can be used in diagnostic and therapeutic applications for diseases associated with abnormal cell growth, such as breast and prostate cancers.

Career Highlights

Throughout his career, Donald G. Jackson has worked with prominent companies, including Bristol-Myers Squibb Company. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Donald has collaborated with notable coworkers, including Liana M. Lee and John N. Feder. These collaborations have further enriched his research and innovation efforts.

Conclusion

Donald G. Jackson's contributions to biotechnology and his innovative patents highlight his significant role in advancing therapeutic interventions for various diseases. His work continues to impact the fields of immunology and cancer research positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…